Mast cell degranulation inhibitors (Allergene)
N/A
Report date: 2023/02/17 20:41:19
Base Information
Drug NameMast cell degranulation inhibitors (Allergene)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergene LtdRamot At Tel Aviv University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRamot At Tel Aviv UniversityAllergene Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A